Unless new treatments are developed to decrease the likelihood of developing Alzheimer’s disease, the number of individuals with Alzheimer’s disease in the United States is expected to be 14 million by the year 2050.
Kui uute ravimeetodite väljatöötamine, et vähendada tõenäosust, arendades Alzheimeri tõbi, isendite arv Alzheimeri tõvega USAs oodatakse 14 miljonit aastas 2050.